Carlos Dedesma
University of North Carolina at Chapel Hill(US)
Publications by Year
Research Areas
Advanced NMR Techniques and Applications, Electron Spin Resonance Studies, Solid-state spectroscopy and crystallography, Molecular spectroscopy and chirality, Advanced MRI Techniques and Applications
Most-Cited Works
- → Ciliary transition zone activation of phosphorylated Tctex-1 controls ciliary resorption, S-phase entry and fate of neural progenitors(2011)242 cited
- → Facile hyperpolarization chemistry for molecular imaging and metabolic tracking of [1–13C]pyruvate in vivo(2023)51 cited
- → Dynein light chain Tctex-1 identifies neural progenitors in adult brain(2006)18 cited
- → Scalable Hyperpolarized MRI Enabled by Ace‐SABRE of [1‐ 13 C]Pyruvate(2025)11 cited
- → Facile hyperpolarization chemistry for molecular imaging and metabolic tracking of [1-13C]pyruvate in vivo(2023)5 cited
- → Advancing SABRE Toward In Vivo Imaging: Phantom Chemical Conversion of Hyperpolarized [1-13C]-Pyruvate(2023)
- → Scalable Hyperpolarized MRI Enabled by Ace-SABRE of [1-13C]Pyruvate(2025)
- → Pt, Cd, Tt and Msr are Co-Founders and Equity Holders of Vizma Life Sciences (Vls). Cd and Pt are Employees of Vls. Eyc is an Equity Holder of Vizma Life Sciences. The Terms of Tt's Arrangement Have Been Reviewed and Approved by Nc State University in Accordance with its Policy on Objectivity in Research. Eyc and Bmg Hold Ownership Stakes in Xeus Technologies Ltd. Msr is a Founder and Equity Holder of Hyperfine Inc. All Other Authors Declare that They Have No Competing Interest(2023)
- → First in vivo experiences with [1-13C]-pyruvate hyperpolarized by SABRE(2024)